BMJ Opinion: Els Torreele: The search for new antibiotics — market-based solutions are not the answer
Els Torreele, executive director of the MSF Access Campaign, discusses market-based research and development (R&D) business models for antibiotic development and calls for “[t]otally different strategies for developing and delivering effective new antibiotics … ones that rely on public responsibility instead of incentives for commercial markets. … The remedy for a deeply flawed innovation ecosystem resides in directing R&D towards improving patient health outcomes and collaboration towards affordable and sustainable access for people in need wherever they live. … We must find the courage to explore radical solutions beyond business as usual because medicines shouldn’t be a luxury” (7/11).